Assyro AI

FDA Orange Book · active-ingredient family

Sulfamethoxazole

Sulfamethoxazole is approved as 2 brand and 7 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:GANTANOL · NDA 013664

2

Brand (NDA)

7

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · suspension, tablet

ProductApplicantApplicationTEApproved
GANTANOLROCHENDA 013664Approved Prior to Jan 1, 1982
GANTANOL×2ROCHENDA 012715Approved Prior to Jan 1, 1982

Generic (ANDA) products (7)

ProductApplicantApplicationTEApproved
SULFAMETHOXAZOLEBARRANDA 087189Jul 25, 1983
SULFAMETHOXAZOLEASCOTANDA 087662Oct 20, 1982
SULFAMETHOXAZOLEHEATHERANDA 086163Approved Prior to Jan 1, 1982
SULFAMETHOXAZOLERISINGANDA 085844Approved Prior to Jan 1, 1982
SULFAMETHOXAZOLEWATSON LABSANDA 086000Approved Prior to Jan 1, 1982
SULFAMETHOXAZOLEWATSON LABSANDA 085053Approved Prior to Jan 1, 1982
UROBAKSHIONOGIANDA 087307Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Sulfamethoxazole — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.